Invention Grant
- Patent Title: Prodrugs of STAT3 inhibitors
-
Application No.: US18446987Application Date: 2023-08-09
-
Publication No.: US12043640B2Publication Date: 2024-07-23
- Inventor: Imran Alibhai , Sofia de Achaval , Jeffrey Larson , Brad Henke
- Applicant: Tvardi Therapeutics, Inc.
- Applicant Address: US TX Sugar Land
- Assignee: Tvardi Therapeutics, Inc.
- Current Assignee: Tvardi Therapeutics, Inc.
- Current Assignee Address: US TX Sugar Land
- Agency: Goodwin Procter LLP
- Main IPC: C07F9/12
- IPC: C07F9/12
Abstract:
Provided herein, in certain embodiments, are compounds of Formula I.
or a pharmaceutically acceptable salt or a solvate thereof, compositions comprising a compounds of Formula I, or a pharmaceutically acceptable salt or a solvate thereof, and uses thereof such as in treating certain diseases or disorders (e.g., cancer, fibrosis, chronic inflammation).
or a pharmaceutically acceptable salt or a solvate thereof, compositions comprising a compounds of Formula I, or a pharmaceutically acceptable salt or a solvate thereof, and uses thereof such as in treating certain diseases or disorders (e.g., cancer, fibrosis, chronic inflammation).
Public/Granted literature
- US20240018172A1 PRODRUGS OF STAT3 INHIBITORS Public/Granted day:2024-01-18
Information query
